Non-Applicability of Criteria of Large Corporate
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hindustan Bio Sciences Ltd has informed BSE that it does not qualify as a 'Large Corporate' under the SEBI circular dated 26 November 2018, which deals with fundraising through debt securities by large entities. The assessment is based on the company's position as of 31 March 2025. The disclosure was made by Managing Director Venkata Rama Mohan Raju Jampana. This is a routine compliance filing and the company appears to be a small-cap entity based on this classification.
This is a routine regulatory disclosure with no direct material impact on shareholders or stock price. It simply confirms the company is not large enough to be subject to additional SEBI borrowing requirements applicable to large corporates.